ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 886 • 2012 ACR/ARHP Annual Meeting

    Association Between Neutrophil Gene Signature and Disease Characteristics in Systemic Lupus Erythematosus Patients

    Michelle Petri1, Hong Fang1, Jadwiga Bienkowska2, Norm Allaire3, Jeff Browning4 and Susan Kalled3, 1Johns Hopkins University School of Medicine, Baltimore, MD, 2Translational Medicine, Biogen Idec Inc., Cambridge, MA, 3Biogen Idec Inc., Cambridge, MA, 4Boston University School of Medicine, Boston, MA

    Background/Purpose: Neutrophils and neutrophil death (“netosis”) are now understood to play a role in the pathogenesis of SLE. A neutrophil gene signature exists in SLE,…
  • Abstract Number: 888 • 2012 ACR/ARHP Annual Meeting

    Plasma Cells Express the Novel Cytokine Interleukin-36α in Psoriatic and Rheumatoid Arthritis Synovium

    Anja Derer1, Silke Frey2, Maria-Elena Messbacher2, Serena Bugatti3, Dominique L. Baeten4, Carlomaurizio Montecucco5, Georg A. Schett1 and Axel J. Hueber6, 1Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 2Internal Medicine 3, University of Erlangen, Erlangen, Germany, 3Rheumatology and Translational Immunology Research Laboratories (LaRIT), Division of Rheumatology, IRCCS Policlinico S.Matteo Foundation/University of Pavia, Pavia, Italy, 4Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 5Division of Rheumatology, University of Pavia School of Medicine, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, 6Department of Internal Medicine 3, University of Erlangen-Nuremberg, Erlangen, Germany

    Background/Purpose: IL-36α is a recent described IL-1 cytokine family member with proinflammatory and clear pathogenic properties in psoriasis. Aim of this study was to determine…
  • Abstract Number: 889 • 2012 ACR/ARHP Annual Meeting

    Modeling Environmental and Genetic Determinants to Identify the Association of Risk Genes in Anti-Ro60-Mediated Injury: Relaxin Receptor I and Tumor Necrosis Factor

    Joanne H. Reed1, Paula S. Ramos2, Jiri Zavadil3, Jill P. Buyon4 and Robert M. Clancy1, 1Medicine, New York University School of Medicine, New York, NY, 2Department of Medicine, Medical University of South Carolina, Charleston, SC, 3Pathology and Center for Health Informatics and Bioinformtics, New York University School of Medicine, New York, NY, 4Department of Medicine, New York University School of Medicine, New York, NY

    Background/Purpose: Fetuses exposed to maternal anti-Ro60 antibodies can develop cardiac conduction abnormalities and life threatening cardiomyopathy; manifestations of neonatal lupus (NL). Recent data support an injury…
  • Abstract Number: 890 • 2012 ACR/ARHP Annual Meeting

    The Role of Adipocytokines in Osteophyte Formation in Osteoarthritis

    Susann Junker1, Grit Krumbholz1, Klaus Frommer1, Angela Lehr2, Stefan Rehart3, Jürgen Steinmeyer4, Markus Rickert5, Georg A. Schett6, Ulf Müller-Ladner7 and Elena Neumann8, 1Department of Internal Medicine and Rheumatology, Kerckhoff-Klinik, Justus-Liebig-University of Giessen, Kerckhoff-Klinik, Bad Nauheim, Germany, 2Dept Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany, 3Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany, 4Dept of Orthopedics and Orthopedic Surgery, University Hospital Gießen and Marburg, Gießen, Germany, 5Dept of Orthopedics and Orthopedic Surgery, University Hospital Giessen and Marburg, Giessen, Germany, 6Dept of Medicine 3, Rheumatology and Clinical Immunology, University of Erlangen-Nuremberg, Erlangen, Germany, 7Internal Medicine and Rheumatology, Justus-Liebig-University of Gießen, Kerckhoff-Klinik, Bad Nauheim, Germany, 8Department of Internal Medicine and Rheumatology, Justus-Liebig-University of Gießen, Kerckhoff-Klinik, Bad Nauheim, Germany

    Background/Purpose: Obesity is an established risk factor in osteoarthritis (OA), but there is not much known about the interaction between bone formation and the so-called…
  • Abstract Number: 891 • 2012 ACR/ARHP Annual Meeting

    Fatty Acids Promote Secretion of Proinflammatory and Prodestructive Factors by Synovial Fibroblasts

    Klaus W. Frommer1, Andreas Schäffler2, Stefan Rehart3, Angela Lehr4, Ulf Müller-Ladner5 and Elena Neumann6, 1Internal Medicine and Rheumatology, Justus-Liebig-University of Gießen, Kerckhoff-Klinik, Bad Nauheim, Germany, 2Department of Internal Medicine III, Endocrinology, Diabetes, Metabolism, Justus-Liebig-University of Giessen, Giessen, Germany, 3Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany, 4Dept Orthopedics and Trauma Surgery, Markus-Hospital, Frankfurt, Germany, 5Department of Internal Medicine and Rheumatology, Justus-Liebig-University of Gießen, Bad Nauheim, Germany, 6Department of Internal Medicine and Rheumatology, Justus-Liebig-University of Gießen, Kerckhoff-Klinik, Bad Nauheim, Germany

    Background/Purpose: Due to their role in inflammatory metabolic diseases, we hypothesized that free fatty acids (FFA) are also involved in primary inflammatory joint diseases including…
  • Abstract Number: 892 • 2012 ACR/ARHP Annual Meeting

    The Epigenetically Repressed Long Noncoding RNA Hotair Influences the Expression of Matrix Metalloproteases in Synovial Fibroblasts

    Michelle Trenkmann1, Matthias Brock2, Renate E. Gay3, Beat A. Michel4, Lars C. Huber2 and Steffen Gay3, 1Center of Experimental Rheumatology, University Hospital Zurich and Zurich Center of Integrative Human Physiology (ZIHP), Zurich, Switzerland, 2Department of Internal Medicine, University Hospital Zurich, Zurich, Switzerland, 3Center of Experimental Rheumatology, University Hospital Zurich, Zurich, Switzerland, 4Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland

    Background/Purpose: Long noncoding RNAs (lncRNA, >200nt) have recently emerged as regulators of gene expression functioning as signals, decoys, guides or scaffolds for transcription factors and/or…
  • Abstract Number: 893 • 2012 ACR/ARHP Annual Meeting

    Nuclear Factor-κB Activation by Type II Collagen Peptide in Osteoarthritic Chondrocytes: Its Inhibition by Hyaluronan Via CD44

    Tadashi Yasuda, Dept of Sports Medicine, Tenri University, Tenri, Japan

    Background/Purpose: Some proteolytic products of cartilage matrix may contribute to cartilage destruction through their catabolic activities. Recently, we have found that a 24-mer synthetic peptide…
  • Abstract Number: 853 • 2012 ACR/ARHP Annual Meeting

    Systemic Sclerosis Classification Criteria: Developing Methods for Multi-Criteria Decision Analysis

    Sindhu R. Johnson1, Raymond P. Naden2, Jaap Fransen3, Frank H.J. van den Hoogen4, Janet E. Pope5, Murray Baron6, Alan G. Tyndall7, Marco Matucci-Cerinic8 and Dinesh Khanna on behalf of ACR/EULAR Classification Criteria SSc9, 1Dept of Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, 2Auckland City Hospital, Auckland, New Zealand, Austria, 3Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 4Rheumatology, Rheumatology Centre Sint Maartenskliniek and Radboud university medical center, Ubbergen (Nijmegen), Netherlands, 5Medicine/Rheumatology, St. Joseph Health Care London, University of Western Ontario, London, ON, Canada, 6Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 7Rheumatology, University of Basel, Basel, Switzerland, 8Medicine, Univ Florence, Firenze, Italy, 9Div of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Classification criteria for systemic sclerosis (SSc) are being developed. Twenty-three candidate criteria have been identified, but need to be reduced. The objectives of this…
  • Abstract Number: 854 • 2012 ACR/ARHP Annual Meeting

    Anti-EIF2B: A Novel Interstitial Lung Disease Associated Autoantibody in Patients with Systemic Sclerosis

    Zoe Betteridge1, Felix Woodhead2, Christopher Bunn3, Christopher D. Denton4, David J. Abraham5, Sujal Desai6, Roland du Bois7, Athol U. Wells8 and Neil McHugh9, 1Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Respiratory, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom, 3Immunology, Royal Free Hospital, London, United Kingdom, 4Department of Rheumatology, Royal Free and University College Medical School, London, England, 5UCL Medical School, London, United Kingdom, 6Radiology, Kings College Hosptial, London, United Kingdom, 7National Jewish Health, Denver, 8Royal Brompton and Harefield NHS Foundation Trust, Department of Radiology, London, United Kingdom, 9Department of Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom

    Background/Purpose: Autoantibodies occur in 75-95% of Systemic Sclerosis (SSc) patients. Studies have shown that the presence of particular SSc-specific autoantibodies (anti-centromere, anti-topoisomerase-1, anti-RNA polymerase III,…
  • Abstract Number: 855 • 2012 ACR/ARHP Annual Meeting

    Identification of a Burkholderia-Like Strain From Temporal Arteries of Subjects with Giant Cell Arteritis

    Curry L. Koening1, Bradley J. Katz2, Jose Hernandez-Rodriguez3, Marc Corbera-Bellalta4, Maria C. Cid5, Herbert P. Schweizer6, Dean Li2, Jerry Kaplan2, Gary S. Hoffman7 and Ivana De Domenico8, 1Internal Medicine, Salt Lake City Veterans Administration, Salt Lake City, UT, 2University of Utah, Salt Lake City, UT, 3Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 4Systemic Autoimmune Diseases, Vasculitis Research Unit. Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 5Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain, 6Colorado State University, Fort Collins, CO, 7Rheumatic & Immunologic Dis, Cleveland Clinic, Cleveland, OH, 8Internal Medicine-Division of Rheumatology, University of Utah, Salt Lake City, UT

    Background/Purpose: Giant cell arteritis (GCA) is a granulomatous vasculitis of large- and medium-sized arteries. An infectious organism has been hypothesized to cause GCA. We used…
  • Abstract Number: 856 • 2012 ACR/ARHP Annual Meeting

    Am80, a Retinoic Acid Receptor Agonist, Ameliorates Murine Vasculitisthrough the Suppression of Neutrophil Migration and Activation

    Chie Miyabe1, Yoshishige Miyabe1, Noriko Miura2, Kei Takahashi3, Yuya Terashima4, Etsuko Toda4, Fumiko Honda5, Tomohiro Morio5, Naohito Ohno2, Jun-ichi Suzuki6, Mitsuaki Isobe7, Kouji Matsushima4, Ryoji Tsuboi8, Nobuyuki Miyasaka1 and Toshihiro Nanki9, 1Department of Medicine and Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan, 2Laboratory for Immunopharmacology of Microbial Products, School of Pharmacy, Tokyo University of Pharmacy and Life Science, Tokyo, Japan, 3Department of Pathology, Toho University Ohashi Medical Center, Tokyo, Japan, 4Department of Molecular Preventive Medicine, The University of Tokyo, Tokyo, Japan, 5Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University, Tokyo, Japan, 6Department of Advanced Clinical Science and Therapeutics, The University of Tokyo, Tokyo, Japan, 7Department of Cardiovascular Medicine, Tokyo Medical and Dental University, Tokyo, Japan, 8Department of Dermatology, Tokyo Medical University, Tokyo, Japan, 9Department of Rheumatology, Tokyo Medical and Dental University, Tokyo, Japan

    Background/Purpose: Vasculitis is characterized by leukocyte infiltration in the vessel walls with destructive damage to mural structures. Retinoids are compounds that bind to retinoic acid…
  • Abstract Number: 857 • 2012 ACR/ARHP Annual Meeting

    Impairment of the Inhibitory PD-1-PD-L1 Axis in Giant Cell Arteritis (GCA)

    Mazen Nasrallah1, Augusto Vaglio2, Shalini Mohan1, Bjorn Hartmann3, Joyce Liao4, Kenneth J. Warrington5, Jorg J. Goronzy3 and Cornelia M. Weyand6, 1Medicine: Immunology and Rheumatology, Stanford University, Stanford, CA, 2Unit of Nephrology, University Hospital of Parma, Parma, Italy, 3Medicine: Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 4Byers Eye Institute at Stanford, Stanford University, Palo Alto, CA, 5Division of Rheumatology, Mayo Clinic, Rochester, MN, 6Medicine, Stanford University School of Medicine, Stanford, CA

    Background/Purpose: Giant cell arteritis (GCA) is an autoimmune syndrome characterized by granuloma formation in the media of medium and large arteries. In a healthy immune…
  • Abstract Number: 858 • 2012 ACR/ARHP Annual Meeting

    Dense Genotyping, Imputation, and Regression Analysis Identifies Multiple Independent Genetic Susceptibility Loci within the HLA Region in Behcet’s Disease

    Travis Hughes1, Adam Adler2, Patrick S. Coit1, Vuslat Yilmaz3, Kenan Aksu4, Nursen Duzgun5, Gokhan Keser4, Ayse Cefle6, Ayten Yazici6, Andac Ergen7, Erkan Alpsoy8, Carlo Salvarani9, Bruno Casali10, Ina Koetter11, Javier Gutierrez-Achury12, Cisca Wijmenga12, Haner Direskeneli13, Guher Saruhan-Direskeneli14 and Amr H. Sawalha1, 1Division of Rheumatology, University of Michigan, Ann Arbor, MI, 2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 3Istanbul University, Istanbul Faculty of Medicine, Department of Physiology, Istanbul, Turkey, 4Dept. of Internal Medicine, Division of Rheumatology, Ege University, Izmir, Turkey, 5Ankara University, Ankara, Turkey, 6Department of Rheumatology, Kocaeli University, Kocaeli, Turkey, 7Okmeydaný Research and Education Hospital, Istanbul, Turkey, 8Department of Dermatology, Akdeniz University, Antalya, Turkey, 9Rheumatology, Arcispedale S Maria Nuova-IRCCS, Reggio Emilia, Italy, 10Molecular Biology Laboratory, Arcispedale S. Maria Nuova,, Reggio Emilia, Italy, 11Robert Bosch Krankenhaus, Stuttgart, Germany, 12Department of Genetics, University Medical Hospital Groningen, University of Groningen, Groningen, Netherlands, 13Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey, 14Department of Physiology, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

    Background/Purpose: The genetic association between HLA-B51 and Behcet’s disease is well established. However, localizing this genetic effect and exploring additional susceptibility loci within the HLA…
  • Abstract Number: 859 • 2012 ACR/ARHP Annual Meeting

    Endothelin-1 (ET-1) Induces Extracellular Matrix Protein Production by Human Temporal Artery Derived Myointimal Cells. A Mechanism Potentially Leading to Intimal Hyperplasia and Vascular Occlusion in Giant-Cell Arteritis

    Ester Planas-Rigol1, Marc Corbera-Bellalta2, Marco A. Alba3, Itziar Tabera-Bahillo3, Sergio Prieto-Gonzalez3, Georgina espigol-Frigole3, Jose Hernandez-Rodriguez4, Ester Lozano5 and Maria C. Cid6, 1Systemic Autoimmune Diseases, Vasculitis Research Unit. Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 2Hospital Clinic University Barcelona, Hospital Clinic University Barcelona, Barcelona, Spain, 3Vasculitis research Unit, systemic autoimmune diseases department. Idibaps., Hospital Clinic University Barcelona, Barcelona, Spain, 4Vasculitis research Unit, systemic autoimmune diseases department. Idibaps., Hospital Clínic. University of Barcelona. IDIBAPS, Barcelona, Spain, 5Vasculitis research Unit, systemic autoimmune diseases department. Idibaps., Hospital Clinic University Barcelona, 6Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clínic University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

    Background/Purpose: Endothelin-1 (ET-1) is the main isoform of the Endothelin family. It is also the most powerful vasoconstrictor identified. ET-1 is constitutively produced in blood…
  • Abstract Number: 860 • 2012 ACR/ARHP Annual Meeting

    Interleukin-21, B Cell Activating Factor and Unmethylated CpG Oligodeoxynucleotides Synergize in Promoting Anti-Proteinase 3 Autoantibody Production in Vitro

    Nikola Lepse1, Judith Land2, Abraham Rutgers2, Cees G.M. Kallenberg2, Coen A. Stegeman3, Peter Heeringa1 and Wayel H. Abdulahad2, 1Pathology and Medical Biology, University Medical Center Groningen, Groningen, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Groningen, Groningen, Netherlands, 3Nephrology, University Medical Center Groningen, Groningen, Netherlands

    Background/Purpose: Anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides (AAV) are characterized by the presence of circulating autoantibodies that are often directed against proteinase 3 (PR3). Although the…
  • « Previous Page
  • 1
  • …
  • 2543
  • 2544
  • 2545
  • 2546
  • 2547
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology